Minimizing unnecessary proBNP blood tests: an evaluation of a pop-up form implementation in general practice.

Objective: To evaluate the impact of a compulsory pop-up form on the ordering pattern of proBNP blood tests by general practitioners in the Capital Region of Denmark.

Design: A follow-up study comparing the average number of proBNP tests ordered before and after the implementation of an intervention.

Setting And Subjects: From 2016 to 2021, the average number of proBNP tests increased by over 300%.

Association of routine hematological parameters with the development of monoclonal gammopathies: a case-control study of 134,740 patients : Resubmitted to annals of Hematology 26 March 2024.

The diagnosis of multiple myeloma requires detection of paraproteinemia and confirmation of monoclonal bone marrow infiltration, along with signs of end-organ damage. Despite the increasing prevalence, serum paraproteinemia is not routinely measured. We examined the relationship between alterations in routine hematological parameters and the development of paraproteinemia in a case-control study.

Dysmagnesemia as a predictor of developing diabetic levels of hemoglobin A1c.

The aim of this study was to assess the possible association between P-Mg and subsequent high levels of HbA The study involves data from primary health care patients and data from patients treated in hospitals located in the capital region of Denmark. P-Mg and HbA levels were analyzed from 121,575 patients in the period 2010-2022. Patients were categorized in a diabetic and non-diabetic group.

Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018.

Objective: To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia.

Design: Epidemiological cohort study.

Setting: Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre.

Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester.

Objectives: The biochemical serum markers free β-human chorionic gonadotropin (hCGβ) and pregnancy associated plasma protein A (PAPP-A), used in screening for trisomy 21 (T21), trisomy 18 (T18), and trisomy 13 (T13) during the first trimester, can be measured on different laboratory instruments e.g. Kryptor (Brahms) and Cobas (Roche).